Machine learning has enormous potential both in preventive care, especially the early diagnosis of diseases like Alzheimer’s and diabetes, as well as in advanced drug discovery. The advent of AlphaFold and other groundbreaking AI tools like it may lead to significantly lower costs in bringing new drugs to market.
Do you have a question for the IEEE Impact Creators?